Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS
- Paulos Gebrehiwet
- , Lisa Meng
- , Stacy A. Rudnicki
- , Phil Sarocco
- , Jenny Wei
- , Andrew A. Wolff
- , Michael Butzner
- , Adriano Chiò
- , Jinsy A. Andrews
- , Angela Genge
- , Dyfrig A. Hughes
- , Carlayne E. Jackson
- , Noah Lechtzin
- , Timothy M. Miller
- , Jeremy M. Shefner
Research output: Contribution to journal › Article › peer-review
3
Link opens in a new tab
Scopus
citations